Trial Profile
Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines (ASCEND).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Aug 2011
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- Acronyms ASCEND
- Sponsors Otsuka Pharmaceutical
- 06 Jul 2011 Secondary endpoint 'Walking-Impairment-Questionnaire' has been met.
- 06 Jul 2011 Primary endpoint 'Assessment-scale-scores' has not been met.
- 03 Mar 2010 New trial record